Chem Labs, Inc. has just developed a superior new drug to treat gastrointestinal disorders (e.g., ulcers). Barriers to market entry (for others) are high and Chem Labs desires a quick return on its investment. Under these circumstances, the most appropriate pricing strategy would be: A) skimming pricing. B) penetration pricing. C) accelerated maturity pricing. D) time series. E) new venture pricing.